Company / Depreciation & Amortization
Ventyx Biosciences, Inc. Depreciation & Amortization History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$266.0K
FY2024
5-year range
$30.0K / $266.0K
FY2021-FY2024
Trend
+68.4%
vs FY2023
Sector context
#170 of 192
Health Care
What the data says
Ventyx Biosciences, Inc.'s depreciation & amortization of $266,000 is lower than 89% of companies in the Health Care sector (FY2024). Depreciation & Amortization has increased for 3 consecutive years, from $30,000 in FY2021 to $266,000 in FY2024.
Based on SEC 10-K filings.
$266,000 in FY2024 with a 3-year CAGR of +107.0%.
Increased from $123,000 to $266,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +107.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-99.9% below sector average
Key checks
Key Insights
- Ventyx Biosciences, Inc.'s depreciation & amortization has grown for 3 consecutive years.
- 3-year CAGR of +107.0%, indicating consistent growth.
- In FY2024, depreciation & amortization increased 68.4% year-over-year.
- Ranks #170 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 3.63 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $266.0K | +68.4% |
| FY2023 | $158.0K | +28.5% |
| FY2022 | $123.0K | +310.0% |
| FY2021 | $30.0K | - |
| FY2020 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026